Dupilumab: Mechanism of action, clinical, and translational science
Abstract Allergic disease prevalence has increased globally with the subset of type 2 inflammatory diseases playing a substantial role. Type 2 inflammatory diseases may differ in clinical presentation, but they exhibit shared pathophysiology that is targeted by the unique pharmacology of dupilumab....
| Published in: | Clinical and Translational Science |
|---|---|
| Main Authors: | , , , , |
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-08-01
|
| Online Access: | https://doi.org/10.1111/cts.13899 |